Clinical Trials Directory

Trials / Completed

CompletedNCT04516928

Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel

Status
Completed
Phase
Study type
Observational
Enrollment
392 (actual)
Sponsor
Direction Centrale du Service de Santé des Armées · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Emerging in China in December 2019, Covid-19, whose pathogen is SARS-Cov-2, was declared a global pandemic in March 2020. The clinical presentation is highly variable, ranging from asymptomatic forms to acute respiratory distress and even death. Transmission is by droplet route, with an R0 of approximately 3. Rapidly, population protection measures were put in place by governments, including the confinement of all persons whose functions were not considered essential and the closure of educational institutions. Health care institutions are places at risk of Covid-19 transmission and hospital staff are particularly exposed, either through direct contact with patients, contact with exposed persons or through the environment. In order to protect personnel, hygiene measures were immediately recalled and reinforced. During the period of containment, the majority of students from the Lyon-Bron Military Medical Schools were sent as reinforcement in Army Training Hospitals and in the Military Reanimation Unit (Mulhouse). Some students developed symptomatic forms of SARS-Cov-2 infection, documented by positive PCR, during Operation Resilience or on their return from the mission. The Lyon-Bron Military Medical Schools staff, exposed both to the initial phase of the epidemic and to national protection measures, represent an extremely interesting population for understanding the epidemiological dynamics of the virus.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAnti-SARS-CoV2 SerologyThe anti-SARS-CoV2 serological status will be measured on a blood sample collected at Day 0.
OTHERQuestionnaireA questionnaire on socio-demographical status, health status and lifestyle habits during the pandemic will be filled by the participants at Day 0.

Timeline

Start date
2020-09-21
Primary completion
2020-09-25
Completion
2020-09-25
First posted
2020-08-18
Last updated
2021-03-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04516928. Inclusion in this directory is not an endorsement.